Issue #24: In Silico Discovery of RIOK3 Inhibitors Against Pancreatic Ductal Adenocarcinoma Using Homology Modelling, Molecular Docking, Molecular Dynamics Simulations, ADMET Prediction, and MTT assay
Protein Design Digest - 2026-01-16 - In Silico Discovery of RIOK3 Inhibitors Against Pancreatic Ductal Adenocarcinoma Using Homology Modelling, Molecular Docking, Molecular Dynamics Simulations, ADMET Prediction, and MTT assay

Building something in Protein Design?
I love collaborating on new challenges. Let's build together.
Subscribe to Protein Design Digest
Daily curated signals from arXiv, PubMed, and BioRxiv.
Signal of the Day
In Silico Discovery of RIOK3 Inhibitors Against Pancreatic Ductal Adenocarcinoma Using Homology Modelling, Molecular Docking, Molecular Dynamics Simulations, ADMET Prediction, and MTT assay
Abstract Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer strongly linked to RIO Kinase 3 (RIOK3), which promotes progression by stabilizing and phosphorylating Focal Adhesion Kinase (FAK). Advances in protein structure prediction, particularly AlphaFold2, have significantly enhanced our understanding of protein dynamics, aiding in the identification of potential inhibitors for targeted therapies. This study used structure-based virtual screening, molecular dynamics simulations, ADMET/toxicity prediction, and in vitro validation to identify potential inhibitors of RIOK3 for PDAC treatment. The 3D structure of RIOK3 was predicted using AlphaFold2 and docked with FDA-approved drugs via AutoDock Vina. Pharmacokinetic and pharmacodynamic properties were assessed with SwissADME, and in vitro validation was performed using MTT assays to assess cell viability and growth inhibition. Four top-scoring compounds were identified, with binding energies between − 11.3 and − 10.4 kcal/mol. Venetoclax showed the most stable complex with RIOK3, followed by Conivaptan and Irinotecan. Drospirenone showed weaker binding. Molecular dynamics simulations and MM/GBSA analysis supported the stability of these complexes. SwissADME and ProTox-II confirmed that the compounds met drug-likeness criteria but exhibited distinct pharmacokinetic and toxicity profiles. In vitro MTT assays showed concentration-dependent growth inhibition in PANC-1 cells, with Conivaptan having the lowest IC₅₀ value. This study identifies RIOK3 as a promising therapeutic target for PDAC, with Venetoclax, Conivaptan, Drospirenone, and Irinotecan as repurposable candidates for further research. Further studies should include biochemical assays, expanded cytotoxicity profiling in multiple PDAC cell lines, and in vivo evaluations to validate RIOK3-targeted therapies for PDAC treatment.
Why this matters: Critical for improving fold accuracy and reducing structural uncertainty in de novo design.
Also Worth Reading
Benchmarking all-atom biomolecular structure prediction with FoldBench.
Accurate prediction of biomolecular complex structures is fundamental for understanding biological processes and rational therapeutic design. Recent advances in deep learning methods, particularly all-atom structure prediction models, have significantly expanded their capabilities to include diverse biomolecular entities, such as proteins, nucleic acids, ligands, and ions. However, comprehensive benchmarks covering multiple interaction types and molecular diversity remain scarce, limiting fair and rigorous assessment of model performance and generalizability. To address this gap, we introduce FoldBench, an extensive benchmark dataset consisting of 1522 biological assemblies categorized into nine distinct prediction tasks. Our evaluations reveal critical performance dependencies, showing that ligand docking accuracy notably diminishes as ligand similarity to the training set decreases, a pattern similarly observed in protein-protein interaction modeling. Furthermore, antibody-antigen predictions remain particularly challenging, with current methods exhibiting failure rates exceeding 50%. Among evaluated models, AlphaFold 3 consistently demonstrates superior accuracy across the majority of tasks. In summary, our results highlight significant advancements yet reveal persistent limitations within the field, providing crucial insights and benchmarks to inform future model development and refinement.
OctoBench: Benchmarking Scaffold-Aware Instruction Following in Repository-Grounded Agentic Coding
Modern coding scaffolds turn LLMs into capable software agents, but their ability to follow scaffold-specified instructions remains under-examined, especially when constraints are heterogeneous and persist across interactions. To fill this gap, we introduce OctoBench, which benchmarks scaffold-aware instruction following in repository-grounded agentic coding. OctoBench includes 34 environments and 217 tasks instantiated under three scaffold types, and is paired with 7,098 objective checklist items. To disentangle solving the task from following the rules, we provide an automated observation-and-scoring toolkit that captures full trajectories and performs fine-grained checks. Experiments on eight representative models reveal a systematic gap between task-solving and scaffold-aware compliance, underscoring the need for training and evaluation that explicitly targets heterogeneous instruction following. We release the benchmark to support reproducible benchmarking and to accelerate the development of more scaffold-aware coding agents.
MetalloDock: Decoding Metalloprotein-Ligand Interactions via Physics-Aware Deep Learning for Metalloprotein Drug Discovery.
Accurate prediction of metalloprotein-ligand interactions is critical for metalloprotein-targeted drug discovery. Conventional docking tools and existing deep learning (DL) models fail to reliably capture metal-ligand interactions, hampering the discovery of potent metalloprotein inhibitors. Here, we propose MetalloDock, the first DL-based docking framework specially designed for metalloprotein targets. By innovatively integrating an autoregressive spatial decoding engine with a physics-constrained geometric generation paradigm, MetalloDock can precisely reconstruct metal coordination geometries and accurately capture metal-ligand interactions, which enhance both the accuracy of metalloprotein-ligand docking and binding affinity prediction. Extensive evaluations on our custom-built benchmark data set demonstrate that MetalloDock outperforms existing methods, including AlphaFold3, in docking success rate and virtual screening performance for metalloprotein targets. In real-world applications, MetalloDock successfully identified multiple novel hit compounds in a virtual screening campaign targeting the prostate-specific membrane antigen. Additionally, it enabled rational drug design for acidic polymerase endonuclease, leading to the discovery of potent inhibitors. These results highlight the broad applicability of MetalloDock in accelerating metalloprotein-targeted drug discovery and provide a standardized framework for future evaluation of metalloprotein-specific docking algorithms.
Research & AI Updates
- The Atomic Revolution: How AlphaFold 3’s Open-Source Pivot Has Redefined Global Drug Discovery in 2026 - FinancialContent — The Atomic Revolution: How AlphaFold 3’s Open-Source Pivot Has Redefined Global Drug Discovery in 2026 FinancialContent.
- ‘Avatar’ Oscar Winner Mark Sagar, Graphic India’s Sharad Devarajan Launch AI Storytelling Studio FaiBLE (Exclusive) - IMDb — ‘Avatar’ Oscar Winner Mark Sagar, Graphic India’s Sharad Devarajan Launch AI Storytelling Studio FaiBLE (Exclusive) IMDb.
From the Industry
- Beyond SBIRs: How NIH Is Reframing Its Role as a Development Partner for Biotech - BioBuzz — Beyond SBIRs: How NIH Is Reframing Its Role as a Development Partner for Biotech BioBuzz.
- US biotech sector poised for 2026 rebound as IPO interest revives - Reuters — US biotech sector poised for 2026 rebound as IPO interest revives Reuters.
- AbbVie inks USD 5.6bn global licensing deal with Chinese biotech for cancer therapy - medwatch.com — AbbVie inks USD 5.6bn global licensing deal with Chinese biotech for cancer therapy medwatch.com.
- Layoff Tracker: Lyra Shutters, EMD Serono Downsizes - BioSpace — Layoff Tracker: Lyra Shutters, EMD Serono Downsizes BioSpace.
- Juvena lands $33.5m to advance more regenerative biologics to the clinic - Longevity.Technology — Juvena lands $33.5m to advance more regenerative biologics to the clinic Longevity.Technology.
- Fierce Biotech Fundraising Tracker ‘26: Proxima pockets $80M; Kinaset’s $103M series B - Fierce Biotech — Fierce Biotech Fundraising Tracker ‘26: Proxima pockets $80M; Kinaset’s $103M series B Fierce Biotech.
- 2026 biotech funding tracker: recent highlights - Labiotech.eu — 2026 biotech funding tracker: recent highlights Labiotech.eu.
Quick Reads
Shaping a pro-carcinogenic hepatic microenvironment by TCDD: An integrated approach combining network toxicology, machine learning, molecular docking, molecular dynamics and experimental validation.
The increasing prevalence of environmental contaminants has raised concerns regarding their potential contribution to hepatic dysfunction and associated diseases. Read more →
In Silico Identification of Lepiotaprocerin C as a Promising PIM-1 Kinase Inhibitor: An Integrated Docking, Molecular Dynamics, MM/PBSA, QSAR, and ADMET Study.
Proviral Integration site for Moloney murine leukemia virus-1 (PIM-1) kinase, a serine/threonine kinase overexpressed in various malignancies, plays a critical role in promoting cell survival and proliferation, making it a promising target for anticancer therapy. Read more →
Evaluation of Drug-Excipient Compatibility of Ibuprofen with Eggshell-Derived Calcium Citrate Using FTIR, DSC, and Molecular Docking Studies
Abstract Ethnomedicinal Relevance : The use of eggshells for nutritional and medicinal purposes has long been documented in African folklore, where crushed or powdered shells are traditionally administered to enhance bone strength, treat calcium deficiency, and promote general well-being. Read more →
Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations to Elucidate the Potential Mechanism of Ermiao San in Osteoarthritis.
This study aims to identify the active components and molecular mechanisms of Ermiao San (EMS) in the treatment of osteoarthritis (OA) through network pharmacology, molecular docking, and molecular dynamics simulations. Read more →
Network pharmacology, molecular docking and molecular dynamics simulation suggest CE-326597 as an antimalarial molecule.
Malaria remains a major health challenge, intensified by the spread of drug-resistant strains. Read more →
Calycosin ameliorates high-altitude pulmonary edema by regulating macrophage polarization through the PPAR-γ/NF-κB pathway: a comprehensive analysis of network pharmacology, molecular docking, and experimental validation.
The rapid ascent to high-altitude regions poses a substantial risk for the development of high-altitude pulmonary edema (HAPE), a serious condition characterized by non-cardiogenic pulmonary edema and associated acute pulmonary hypertension. Read more →
Virtual screening of sweet peptides from milk protein and molecular dynamics simulations mechanism analysis.
Bioactive peptides derived from milk proteins have attracted increasing interest due to their potential as natural sweet-tasting compounds. Read more →
DeFlow: Decoupling Manifold Modeling and Value Maximization for Offline Policy Extraction
We present DeFlow, a decoupled offline RL framework that leverages flow matching to faithfully capture complex behavior manifolds. Read more →
Pipeline Tip
Always validate pLDDT scores before using AlphaFold models for docking.
Resources & Tools
- Dataset: BioLiP - Verified biologically relevant ligand-protein interactions.
- Dataset: SIFTS - Residue-level mapping between PDB, UniProt, and other resources.
- Tool: AlphaFold2 - Deep learning system for high-accuracy protein structure prediction. View all tools →
- Tool: ColabFold - Fast AlphaFold2/MMseqs2 pipeline for large-scale predictions. View all tools →
- Event: Protein Design Hub (LinkedIn Group) (Ongoing)
- Event: Structural Biology Events (Open)
- Job: Research Associate in Computational Biology and Machine Learning at Loughborough University - Jobs.ac.uk at Jobs.ac.uk
- Job: Research Assistant - Computational at University of Glasgow - Jobs.ac.uk at Jobs.ac.uk
The protein structure is the language of life; design is its poetry. — Recep Adiyaman